Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation.
- Resource Type
- Article
- Source
- International Journal of Environmental Research & Public Health; Jan2023, Vol. 20 Issue 1, p512, 13p
- Subject
- Language
- ISSN
- 16617827